David Tamang
David Tamang publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors and Multiple Myeloma Research and Treatments.
- World rank
- #2,291,311 of 7,710,434 ranked researchers
- Rank in United States
- #683,898 of 1,627,098
- Works
- 54
- Citations
- 2.3k
- Citations per work
- 42.8
What does David Tamang research?
David Tamang's work is mostly in Biochemistry, Genetics and Molecular Biology (39%), Medicine (31%), Immunology and Microbiology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences2750.7%
- Health Sciences1730.6%
- Medicine1730.6%
- Everything else1018.7%
- 1Molecular Biology36% of their works
- 2Oncology18% of their works
- 3Immunology12% of their works
- 4Hematology10% of their works
- 5Pulmonary and Respiratory Medicine3% of their works
- 6Cell Biology2% of their works
Research topics
Which keywords describe David Tamang's research?
The keywords of their largest research topics: Cancer Therapy, HDAC Inhibitors, Histone Deacetylases, BET Bromodomains, PROTACs, Tumor Microenvironment, Diagnosis Criteria and Fibroblast Activation Protein.
- Stress
- Endoplasmic Reticulum
- PD-1 and PD-L1
- NK Cell Recognition
- International Myeloma Working Group
- Fibroblast Activation Protein
- Tumor Microenvironment
- BET Bromodomains
- HDAC Inhibitors
- Cancer Therapy
- Histone Deacetylases
- PROTACs
- Diagnosis Criteria
- Immunosuppression
- Immune Checkpoint Blockade
- Natural Killer Cells
- Dendritic Cells
- Immunity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Cancer Therapy412 topics
- HDAC Inhibitors271 topic
- Histone Deacetylases271 topic
- BET Bromodomains211 topic
- PROTACs211 topic
- Tumor Microenvironment212 topics
- Diagnosis Criteria141 topic
- Fibroblast Activation Protein141 topic
- Immunosuppression141 topic
- International Myeloma Working Group141 topic
- Immune Checkpoint Blockade71 topic
- NK Cell Recognition71 topic
- Natural Killer Cells71 topic
- PD-1 and PD-L171 topic
- Dendritic Cells41 topic
- Endoplasmic Reticulum41 topic
- Immunity41 topic
- Stress41 topic
Where does David Tamang work?
David Tamang's main affiliation in the publication record is Acetylon Pharmaceuticals (United States), United States.
How many publications and citations does David Tamang have?
OpenAlex counts 54 works and 2,310 citations for David Tamang, an h-index of 16, ranking #2,291,311 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David Tamang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.